Latest Mass Tort News and Updates

Portola Pharmaceuticals received news of a second-time delay from the U.S. Food & Drug Administration (FDA) regarding the approval of AndexXa, an antidote developed to monitor uncontrollable bleeding linked to Xarelto and Eliquis.…

Eli Lilly and Company, the maker of Axiron used in the treatment of low testosterone levels is one of the defendants in the over 6,000 centralized …

Bayer received good news beginning of the year as the Missouri Supreme Court ruled in its favor regarding an Essure Lawsuit filed by 92 women for injuries allegedly caused…

The rising number of recalls, over the past years, on pharmaceutical products containing the cancer-causing chemical N-nitrosodimethylamine (NDMA) has made the drug industry to look for ways to prevent contamination.

Popular medication…

On Friday, Thomas Weaver, the attorney representing Johnson & Johnson (J&J) argued over a bid to reverse a jury’s $4.7 billion talcum powder verdict stating that the judge…

The first AndroGel bellwether trial announced in favor of the plaintiff awarding him $150 million as punitive damages and no compensatory damages in June 2017 was tossed by the U.S. District Judge Matthew F. Kennelly, overseeing 6,000 plus…

Lawsuits involving Nexium, Prilosec, Prevacid, and other proton pump inhibitors have grown up to nearly 14,000 cases filed across the federal court system.

According to a joint…

Two new pretrial orders issued in the U.S. District Court, Southern District of Florida has accelerated the federal multidistrict litigation established for all Zantac lawsuits.

Closely following the heels of the Eli Lilly settlement announcement to resolve all Axiron lawsuits belonging to the MDL 2545 earlier this year…

Last week, a group of 12 Missouri hospitals joined the suit against opioid manufacturers, distributors, and retailers by filing a civil lawsuit in the Greene County Circuit Court.…